Tricuspid valve replacement with the St. Jude Medical valve: 19 years of experience.

OBJECTIVE The choice of the valve substitute in the tricuspid position remains controversial. A St. Jude Medical valve is a choice of valve substitute and its lower thrombogenicity and excellent hemodynamic performance have been reported even in the tricuspid position. However, little is known of the long-term durability of the St. Jude Medical valve in the tricuspid position. Our long-term experience of tricuspid valve replacement showed the higher thrombogenicity than we had expected, therefore, this study was done to reconsider our strategy for valve choice. METHODS This study reviewed 23 patient who underwent 25 tricuspid valve replacements with the St. Jude Medical valves from 1980 to 1997. The mean age was 40 years. Eleven patients (48%) were men. There were four in-hospital deaths (17%). The remaining 19 patients were all alive and followed from 2.2 to 19.0 years (mean 11.8 years). RESULTS The overall survival, including hospital mortality, was 83%, 10 and 15 years after surgery. Valve thrombosis occurred in six patients. Freedom from valve thrombosis was 78 and 70%, 10 and 15 years after surgery, respectively. The linearized rate of the valve thrombosis was 2.9%/patient-years. Six patients required reoperation. The mean interval to reoperation was 9.5 years. Freedom from reoperation was 83% and 75%, 10 and 15 years after surgery, respectively. The linearized rate of the reoperation was 2.8%/patient-years. No structural valve deterioration was found. Echocardiographic study showed that the function of the St. Jude Medical valve without valve-related complications was well maintained. CONCLUSIONS The higher thrombogenicity of the St. Jude Medical valve in the tricuspid position altered our choice of valve substitutes from the St. Jude Medical valve to a bioprosthesis which is lack of need for anticoagulant therapy except for juvenile patients who are able to maintain potent anticoagulant therapy.

[1]  S. Aoyagi,et al.  Long-term results of valve replacement with the St. Jude Medical valve. , 1994, The Journal of thoracic and cardiovascular surgery.

[2]  C. Thorburn,et al.  Long-term results of tricuspid valve replacement and the problem of prosthetic valve thrombosis. , 1983, The American journal of cardiology.

[3]  F Clerc,et al.  Long-term results of valve replacement with the St. Jude Medical prosthesis. , 1995, The Journal of thoracic and cardiovascular surgery.

[4]  L. Cohn,et al.  Guidelines for reporting morbidity and mortality after cardiac valvular operations. , 1996, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[5]  D. Williams,et al.  Follow-up assessment of St. Jude Medical prosthetic valve in the tricuspid position: clinical and hemodynamic results. , 1984, The Annals of thoracic surgery.

[6]  J. Hayashi,et al.  Is a bioprosthesis preferable in tricuspid valve replacement? , 1996, The Thoracic and cardiovascular surgeon.

[7]  W. White,et al.  In-hospital and long-term outcome after porcine tricuspid valve replacement. , 1995, The Journal of thoracic and cardiovascular surgery.

[8]  C. Armstrong,et al.  Tricuspid valve replacement. Fifteen years of experience with mechanical prostheses and bioprostheses. , 1995, The Journal of thoracic and cardiovascular surgery.

[9]  J. M. Bernal,et al.  Tricuspid valve replacement in rheumatic disease: preoperative predictors of hospital mortality. , 1996, The Journal of heart valve disease.

[10]  C. Doré,et al.  Tricuspid valve replacement: UK Heart Valve Registry mid-term results comparing mechanical and biological prostheses. , 1998, The Annals of thoracic surgery.

[11]  W. Williams,et al.  Tricuspid valve replacement in children. , 1987, Annals of Thoracic Surgery.

[12]  H. Ueda,et al.  Ten-year experience with the Carpentier-Edwards pericardial xenograft in the tricuspid position. , 1996, The Journal of thoracic and cardiovascular surgery.

[13]  W. Feng,et al.  Long-term results of St. Jude Medical valve in the tricuspid position. , 1992, The Annals of thoracic surgery.

[14]  R. Tominaga,et al.  Excellent durability of the Hancock porcine bioprosthesis in the tricuspid position. A sixteen-year follow-up study. , 1992, The Journal of thoracic and cardiovascular surgery.

[15]  I. Elezović,et al.  Late thrombosis of the Björk-Shiley tilting disc valve in the tricuspid position. Thrombolytic treatment with streptokinase. , 1986, The Journal of thoracic and cardiovascular surgery.

[16]  H. Koyanagi,et al.  Tricuspid valve replacement with the bileaflet St. Jude Medical valve prosthesis. , 1994, The Journal of thoracic and cardiovascular surgery.

[17]  G. Primo,et al.  The valve choice in tricuspid valve replacement: 25 years of experience. , 1995, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.